Artivion AORT Aortic stent grafts — Total revenues

Other product segments

Similar metrics at other companies

EWTranscatheter Aortic Valve Replacement — Net Sales

$1.2B+14.4%

ASSTMedical Device — Total revenues

$1.37M—

BLCODevices — Total revenues

$480M+7.1%

IAR

IARTInstruments — Total Revenues

$47.23M-7.3%

ATECProducts And Services — Revenue (Gross)

$192.11M+13.6%

BLCOSurgical — Total revenues

$228M+6.5%

Questions, answered.

What is Artivion's aortic stent grafts — total revenues?

Artivion (AORT) reported aortic stent grafts — total revenues of $44.4M in Q1 2026.

How has Artivion's aortic stent grafts — total revenues changed year-over-year?

Artivion's aortic stent grafts — total revenues increased by 21.3% year-over-year, from $36.6M to $44.4M.

What is the long-term trend for Artivion's aortic stent grafts — total revenues?

Over 4 years (2021 to 2025), Artivion's aortic stent grafts — total revenues has grown at a 16.9% compound annual growth rate (CAGR), from $85.39M to $159.37M.

What does aortic stent grafts — total revenues mean?

This metric represents the total gross revenue generated from the sale of aortic stent graft products within a specific reporting period. It serves as a key indicator of market adoption and commercial performance for the company's specialized endovascular repair portfolio. Investors use this to evaluate the growth trajectory and competitive positioning of the firm's aortic-centric medical device offerings.